Prospective evaluation of neuromediators during treatment with docetaxel in castration resistant prostate cancer.

Jost von Hardenberg,Maike Schwartz,Christian Bolenz,Christel Weiss,Thorsten Werner,Stefan Fuxius,Markus Mueller,Thomas Frangenheim,Elmar Heinrich

Prospective evaluation of neuromediators during treatment with docetaxel in castration resistant prostate cancer.

2016

Jost von Hardenberg
Maike Schwartz
Christian Bolenz
Christel Weiss
Thorsten Werner
Stefan Fuxius
Markus Mueller
Thomas Frangenheim
Elmar Heinrich

e16609Background: Small-cell/neuroendocrine (SCNC) transformation in castration resistant prostate cancer (CRPC) treated with highly effective AR axis inhibitors has been observed. Similarly, it ha...

Keywords:

Urology
Pathology
Prostate cancer
Castration
Medicine
Docetaxel
Oncology
castration resistant
Internal medicine
prospective evaluation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations